title: 58th American Society of Hematology Annual Meeting.
authors.forename: Lan-Lan
authors.initials: LL
authors.lastname: Smith
mesh_terms: D000071120:ADAMTS13 Protein / Q000627:therapeutic use; D000225:Adenine / Q000031:analogs & derivatives; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D062905:Central Venous Catheters / Q000009:adverse effects; D015316:Genetic Therapy / Q000379:methods; D006086:Graft vs Host Disease / Q000188:drug therapy; D006402:Hematologic Diseases / Q000235:genetics / Q000628:therapy*; D002836:Hemophilia B / Q000235:genetics / Q000628:therapy; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000628:therapy; D009101:Multiple Myeloma / Q000188:drug therapy; D009154:Mutation; D010880:Piperidines; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011697:Purpura, Thrombotic Thrombocytopenic / Q000628:therapy; D011720:Pyrazoles / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D012955:Societies, Medical; D013927:Thrombosis / Q000209:etiology; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; D011994:Recombinant Proteins; C551803:ibrutinib; C556306:daratumumab; C497970:FLT3 protein, human; D051941:fms-Like Tyrosine Kinase 3; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human; D000225:Adenine